DexCom Inc (DXCM)
68.99
-0.71
(-1.02%)
USD |
NASDAQ |
Nov 05, 16:00
69.01
+0.02
(+0.03%)
After-Hours: 18:53
DexCom Price: 68.99 for Nov. 5, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Nov 04, 2024 | 70.88 | 71.01 | 69.65 | 69.70 | 3.004M |
Nov 01, 2024 | 70.10 | 71.09 | 69.88 | 70.35 | 2.735M |
Oct 31, 2024 | 71.50 | 71.61 | 69.74 | 70.48 | 4.044M |
Oct 30, 2024 | 72.10 | 72.56 | 71.09 | 71.80 | 3.567M |
Oct 29, 2024 | 72.25 | 72.58 | 70.88 | 72.24 | 4.165M |
Oct 28, 2024 | 73.48 | 74.60 | 71.60 | 72.10 | 5.566M |
Oct 25, 2024 | 73.40 | 76.06 | 70.88 | 73.44 | 14.56M |
Oct 24, 2024 | 73.21 | 75.13 | 73.03 | 74.85 | 9.945M |
Oct 23, 2024 | 72.32 | 73.23 | 72.20 | 72.48 | 4.293M |
Oct 22, 2024 | 72.10 | 73.12 | 71.84 | 73.08 | 2.778M |
Oct 21, 2024 | 71.87 | 73.79 | 71.81 | 72.61 | 3.233M |
Oct 18, 2024 | 69.50 | 72.40 | 69.26 | 72.38 | 3.695M |
Oct 17, 2024 | 69.90 | 70.40 | 69.20 | 69.55 | 3.801M |
Oct 16, 2024 | 67.59 | 69.96 | 67.58 | 69.90 | 4.704M |
Oct 15, 2024 | 69.00 | 69.09 | 67.04 | 67.10 | 5.620M |
Oct 14, 2024 | 69.81 | 69.81 | 68.19 | 69.18 | 3.483M |
Oct 11, 2024 | 69.98 | 70.02 | 69.06 | 69.21 | 3.942M |
Oct 10, 2024 | 69.16 | 70.00 | 68.57 | 69.56 | 4.719M |
Oct 09, 2024 | 69.17 | 69.72 | 68.83 | 69.62 | 2.625M |
Oct 08, 2024 | 68.86 | 69.63 | 68.57 | 69.43 | 3.944M |
Oct 07, 2024 | 68.10 | 69.57 | 67.81 | 68.62 | 3.605M |
Oct 04, 2024 | 66.45 | 68.99 | 66.22 | 68.11 | 6.337M |
Oct 03, 2024 | 66.82 | 67.15 | 65.58 | 65.68 | 3.457M |
Oct 02, 2024 | 65.70 | 67.19 | 64.76 | 67.10 | 3.772M |
Oct 01, 2024 | 67.39 | 67.39 | 65.29 | 66.00 | 3.938M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
38.28
Minimum
Nov 06 2019
162.82
Maximum
Nov 17 2021
102.05
Average
103.53
Median
Feb 17 2021
Price Benchmarks
Orthofix Medical Inc | 17.71 |
Abbott Laboratories | 117.71 |
Bristol-Myers Squibb Co | 55.94 |
Edwards Lifesciences Corp | 66.69 |
Tandem Diabetes Care Inc | 33.13 |
Price Related Metrics
PE Ratio | 41.31 |
PS Ratio | 7.244 |
PEG Ratio | 0.4946 |
Price to Book Value | 13.62 |
Price to Free Cash Flow | 53.54 |
Earnings Yield | 2.42% |
Market Cap | 26.95B |
PEGY Ratio | 0.4946 |
Operating PE Ratio | 45.61 |
Normalized PE Ratio | 41.31 |